AIM ImmunoTech Inc.
AIM
$0.26
-$0.01-2.02%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.28M | -13.96M | -15.75M | -16.17M | -15.21M |
| Total Depreciation and Amortization | 195.00K | 210.00K | 231.00K | 240.00K | 246.00K |
| Total Amortization of Deferred Charges | 671.00K | 552.00K | 321.00K | 214.00K | 292.00K |
| Total Other Non-Cash Items | 3.25M | 3.12M | 1.61M | 1.38M | 1.92M |
| Change in Net Operating Assets | -2.16M | -878.00K | 662.00K | 3.37M | 320.00K |
| Cash from Operations | -11.32M | -10.96M | -12.93M | -10.96M | -12.43M |
| Capital Expenditure | -- | -- | 0.00 | -18.00K | -18.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 918.00K | 1.85M | 5.65M | 5.71M | 5.78M |
| Cash from Investing | 918.00K | 1.85M | 5.65M | 5.69M | 5.76M |
| Total Debt Issued | 2.75M | 2.75M | 250.00K | 383.00K | 0.00 |
| Total Debt Repaid | -860.00K | -660.00K | -911.00K | -251.00K | -251.00K |
| Issuance of Common Stock | 11.18M | 7.68M | 7.71M | 801.00K | 1.22M |
| Repurchase of Common Stock | -6.70M | -6.70M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.94M | 7.31M | 1.65M | 1.26M | 3.30M |
| Cash from Financing | 15.32M | 10.39M | 8.71M | 2.19M | 4.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.92M | 1.28M | 1.43M | -3.08M | -2.40M |